Loading ETF profile…
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities that compose the fund's index. The index is designed to comprise securities in the healthcare sector within the U.S. Universe whose market capitalizations are larger than that of the 1001st largest U.S. company at the time of reconstitution. The fund is non-diversified.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| UNH | UnitedHealth Group Incorporated | 6.00% | $2.91M |
| JNJ | Johnson & Johnson | 5.55% | $2.69M |
| PFE | Pfizer Inc. | 2.97% | $1.44M |
| MRK | Merck & Co., Inc. | 2.84% | $1.38M |
| TMO | Thermo Fisher Scientific Inc. | 2.35% | $1.14M |
| ABBV | AbbVie Inc. | 2.23% | $1.08M |
| LLY | Eli Lilly and Company | 2.22% | $1.08M |
| ABT | Abbott Laboratories | 2.17% | $1.05M |
| ANTM | Anthem, Inc. | 2.02% | $980.79K |
| BMY | Bristol-Myers Squibb Company | 2.00% | $971.08K |
| MDT | Medtronic plc | 1.93% | $937.09K |
| AMGN | Amgen Inc. | 1.78% | $864.26K |
| DHR | Danaher Corporation | 1.77% | $859.40K |
| IQV | IQVIA Holdings Inc. | 1.72% | $835.12K |
| CI | Cigna Corporation | 1.64% | $796.28K |
| CVS | CVS Health Corporation | 1.61% | $781.72K |
| HUM | Humana Inc. | 1.42% | $689.46K |
| A | Agilent Technologies, Inc. | 1.40% | $679.75K |
| ZTS | Zoetis Inc. | 1.39% | $674.90K |
| BIIB | Biogen Inc. | 1.39% | $674.90K |
| BDX | Becton, Dickinson and Company | 1.28% | $621.49K |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.25% | $606.92K |
| RMD | ResMed Inc. | 1.24% | $602.07K |
| LH | Laboratory Corporation of America Holdings | 1.20% | $582.65K |
| ZBH | Zimmer Biomet Holdings, Inc. | 1.19% | $577.79K |